Podcasts about Imaging

Welcome to this week's Midlife Minute episode! Statistically, one in three women will die of heart disease. So, today, we're answering some of the many questions I received about lipids and heart health. Although I've done other lipid-focused Midlife Minutes before, this episode is yet another dedicated to Dr. Tom Dayspring, as I've received such a vast number of questions on this particular topic.    IN THIS EPISODE, YOU WILL LEARN: Why understanding your ApoB and Lp(a) is an essential part of assessing your cardiovascular risk Why treatments for lipid abnormalities should be individualized to fit each specific abnormality  Essential lifestyle measures for supporting overall cardiovascular health How CAC scoring, CT coronary angiography, and Clearly AI-assisted imaging differ, what each test measures, and their limitations  How cardiovascular disease can sometimes present differently in women  Why are premature atrial contractions and premature ventricular contractions often benign when the heart is structurally normal? How the roles of statins, ezetimibe, PCSK9 inhibitors, GLP-1 medications, and emerging RNA therapies differ, and why they should not be considered interchangeable How declining estrogen impacts cardiovascular health Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website. Submit your questions to support@cynthiathurlow.com  Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow.  Purchase Cynthia's book, The Menopause Gut. Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line

When to image, when to wait, and what to do when the ideal test isn't available are often far more nuanced than they appear. In this EM Cases episode, Dr. Amit Shah joins Anton to tackle some of the toughest everyday imaging decisions: How much should cumulative radiation exposure influence our decision to order another CT? In suspected appendicitis, when is it safe to wait for ultrasound rather than obtain CT overnight? Can the emerging traumatic brain injury biomarkers GFAP and UCH-L1 help avoid CT, particularly in rural and remote settings? And in suspected cauda equina syndrome, how can PVR and CT lumbar spine be combined to risk-stratify patients when MRI isn't immediately available—and when should a reassuring PVR or CT not reassure us? Plus, practical shared decision-making strategies, the role of the “tincture of time,” and much more... Please consider a donation to EM Cases to support ongoing high-quality Free Open Access Medical Education: https://emergencymedicinecases.com/donation/

How do you navigate the evolving science and controversy of concussion care in athletes and beyond? On this episode of BackTable Bone & Sports, Dr. Larry Balle welcomes Dr. Ryan Stempniak to break down the fundamentals and emerging advances in concussion management. They define concussion pathophysiology, highlight why most injuries occur without loss of consciousness, and discuss delayed symptom onset that can complicate diagnosis and treatment. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction07:16 - Who Manages Concussions?12:21 - Defining and Understanding Concussions23:31 - Injury Mechanisms and Pathophysiology26:56 - Recognizing and Grading Symptoms35:00 - Assessment Tools: SCAT6 vs. SCOAT38:34 - Return-to-Play and Return-to-Learn50:42 - Medications, Supplements, and Treatment Advances57:10 - Concussion Subtypes and Individualized Care01:02:01 - Helmets, Wearables, and Emerging Technology01:10:11 - AI, Imaging, and Research Directions01:13:01 - Myths, Facts, and Protocol Updates01:16:57 - Closing Thoughts --- More about this episode The conversation covers mechanisms of injury, symptom assessment, sideline and office evaluation, and the critical role of return-to-learn before return-to-play. Drs. Balle and Stempniak discuss concussion subtypes, medication and supplement limitations, and the latest on helmets, wearables, and AI-driven research. They also emphasize individualized care plans, the importance of school and work accommodations, and practical strategies for clinicians managing this complex and ever-changing condition. --- ResourcesDr. Ryan Stempniakhttps://www.linkedin.com/in/ryan-stempniak-843545295/ --- BackTable Bone & Sports is the go-to podcast for orthopedic surgeons, sports medicine docs, pain specialists, and MSK radiologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

CardioNerds (Drs. Dr. Natalie Marrero, Dr. Ritika Tuli, and Dr. Rafael Toro Manotas) discuss multimodality imaging for risk stratification, evaluation, and management of chronic coronary artery disease with Dr. Panithaya Chareonthaitawee. Audio editing by CardioNerds intern Iman Razeghian. This episode was produced as part of the CardioNerds Academy curriculum by House Taussig under the guidance of House Chief, Dr. Natalie Marrero and Academy Program Director, Dr. Gurleen Kaur. A matching review article will be published in US Cardiology Review, the official journal of CardioNerds. This discussion was planned in collaboration with the Mayo Clinic Cardiovascular Board Review Course. In this episode, we discuss the pathophysiology and risk stratification of chronic coronary artery disease (CAD), as well as the current landscape of non-invasive evaluation of this condition. CAD remains a leading cause of morbidity and mortality despite advances in pharmacological and non-pharmacological strategies for the prevention and treatment of atherosclerotic disease. The concept of chronic CAD has shifted from the traditional model of stable, obstructive, flow-limiting disease, toward the current understanding of a dynamic process that extends beyond obstructive epicardial lesions to include non-obstructive plaque, diffuse atherosclerosis, and microvascular disease. Similarly, the imaging modalities used to evaluate CAD have evolved, and clinicians now have an extensive menu of options, each with distinct advantages and limitations, that must be selected carefully to maximize diagnostic accuracy and optimize treatment guidance, while also considering resource availability, local expertise, and high-value care. By the end of the episode, listeners will understand the pathophysiology of chronic CAD, risk-stratify patients with suspected CAD, recognize the advantages and pitfalls of each non-invasive diagnostic modality, and select the most appropriate diagnostic tool for a given clinical scenario. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. CardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls: Chronic CAD is a complex process that extends beyond obstructive epicardial stenosis to include non-obstructive disease, dynamic plaque burden and ischemia, diffuse atherosclerosis, microvascular dysfunction, vasospasm, among others. When evaluating patients with suspected CAD, the diagnostic process should be guided by a specific and appropriate clinical question before ordering any tests. The current diagnostic tool arsenal is broadly divided into anatomic and functional imaging modalities. These are complementary, each with distinct properties and limitations, addressing different clinical questions and assessing different aspects of disease. Local availability and expertise, along with patient-specific considerations and contraindications, determine the choice of diagnostic modality. No single test is best for every patient. INOCA and coronary microvascular dysfunction represent a common and increasingly recognized entity that is diagnosable and treatable; initial evaluation includes non-invasive testing such as stress PET and stress CMR. References Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144(22):e368-e454. doi:10.1161/CIR.0000000000001029 https://pubmed.ncbi.nlm.nih.gov/34709879/ Vrints C, Andreotti F, Koskinas KC, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415-3537. doi:10.1093/eurheartj/ehae177 https://pubmed.ncbi.nlm.nih.gov/39210710/ Virani SS, Newby LK, Arnold SV, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023;148(9):e9-e119. doi:10.1161/CIR.0000000000001168 https://pubmed.ncbi.nlm.nih.gov/37471501/ Edvardsen T, Asch FM, Davidson B, et al. Non-Invasive Imaging in Coronary Syndromes: Recommendations of The European Association of Cardiovascular Imaging and the American Society of Echocardiography, in Collaboration with The American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2022;35(4):329-354. doi:10.1016/j.echo.2021.12.012 https://pubmed.ncbi.nlm.nih.gov/35379446/ Douglas PS, Hoffmann U, Patel MR, et al. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med. 2015;372(14):1291-1300. doi:10.1056/NEJMoa1415516 https://pubmed.ncbi.nlm.nih.gov/39210710/ Sharma A, Coles A, Sekaran NK, et al. Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease. J Am Coll Cardiol. 2019;73(8):893-902. doi:10.1016/j.jacc.2018.11.056 https://pubmed.ncbi.nlm.nih.gov/30819356/ SCOT-HEART Investigators, Newby DE, Adamson PD, et al. Coronary CT Angiography and 5-Year Risk of Myocardial Infarction. N Engl J Med. 2018;379(10):924-933. doi:10.1056/NEJMoa1805971 https://pubmed.ncbi.nlm.nih.gov/30145934/ Li Z, Xu T, Wang Z, et al. Prognostic Significance of Computed Tomography-Derived Fractional Flow Reserve for Long-Term Outcomes in Individuals With Coronary Artery Disease. J Am Heart Assoc. 2025;14(2):e037988. doi:10.1161/JAHA.124.037988 https://pubmed.ncbi.nlm.nih.gov/39791423/ Bateman TM, Al-Mallah MH, et al. Clinical indications for positron emission tomography myocardial perfusion imaging and myocardial blood flow quantification: An American Society of Nuclear Cardiology position statement. J Nucl Cardiol. 2026;57:102619. doi:10.1016/j.nuclcard.2025.102619 https://pubmed.ncbi.nlm.nih.gov/41482140/ Taqueti VR, Di Carli MF. Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018;72(21):2625-2641. doi:10.1016/j.jacc.2018.09.042 https://pubmed.ncbi.nlm.nih.gov/30466521/ Taqueti VR, Hachamovitch R, Murthy VL, et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015;131(1):19-27. doi:10.1161/CIRCULATIONAHA.114.011939 https://pubmed.ncbi.nlm.nih.gov/25400060/ Mehta PK, Huang J, Levit RD, Malas W, Waheed N, Bairey Merz CN. Ischemia and no obstructive coronary arteries (INOCA): A narrative review. Atherosclerosis. 2022;363:8-21. doi:10.1016/j.atherosclerosis.2022.11.009 https://pubmed.ncbi.nlm.nih.gov/36423427/ Kunadian V, Chieffo A, Camici PG, et al. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. EuroIntervention. 2021;16(13):1049-1069. doi:10.4244/EIJY20M07_01 https://pubmed.ncbi.nlm.nih.gov/32624456/

CardioNerds (Dr. Apoorva Gangavelli, Dr. Cory Sejo, and Dr. Joseph Kassab), discuss tricuspid regurgitation evaluation and management with Dr. Sunil Mankad. This episode was produced as part of the CardioNerds Academy curriculum by House Einthoven under the guidance of House Chief, Dr. Apoorva Gangavelli and Academy Program Director, Dr. Gurleen Kaur. A matching review article will be published in US Cardiology Review, the official journal of CardioNerds. This discussion was planned in collaboration with the Mayo Clinic Cardiovascular Board Review Course.  Audio editing by CardioNerds intern Emma Winakur. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. CardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Key Points: Tricuspid regurgitation is common and associated with increased mortality at every stage, regardless of etiology. Outcomes are worse with worsening severity, so accurate grading is critical. Etiology is critical to guide treatment decisions. Etiology includes primary vs secondary (atrial or ventricular) vs CIED-related TR. 3D echocardiography can be very helpful in determining TR etiology, especially in CIED-related TR. Diuresis with the goal of euvolemia is step one. Additionally, underlying contributory conditions (eg. pulmonary HTN, HFrEF, atrial fibrillation) should be addressed, if appropriate, and then TR severity reassessed. The choice between T-TEER and TTVR hinges on anatomy, RV function, pulmonary hypertension, and the ability to tolerate anticoagulation. T-TEER is generally first line in atrial functional TR with appropriate anatomy, in patients with poor RV function who cannot tolerate a sudden increase in RV afterload, or in patients who cannot tolerate the necessary anticoagulation with TTVR. TTVR is preferred with wide coaptation gaps and CIED-related TR. This is a team sport. Multidisciplinary discussions utilizing imaging (TTE/TEE, CT), risk scores (TRI-SCORE or TRIO), patient preference, and prior institutional experience are essential for the effective treatment of severe TR. Notes: What is the clinical importance of tricuspid regurgitation? TR is very common with approximately 4% of people over 75 having moderate or greater severity. TR (even mild) is associated with increased mortality. Those outcomes worsen as the TR severity worsens, and this phenomenon is independent of the mechanism of regurgitation. What is unique about the tricuspid valve compared to the other cardiac valves? It is at an anterior location which allows it to be imaged well with transthoracic echocardiography It is the largest valve and composed generally of 3 leaflets (but very often can have 4+ leaflets). Importantly, the RV is compliant and changes size and shape readily based on loading conditions. The TV annulus similarly changes size and shape based on hemodynamic conditions such as preload. What is a good framework for approaching the causes of tricuspid regurgitation? Determine the presence and define the severity of TR. Using TTE, we want to measure the right atrial size, the RV size, and any other concomitant valvular lesions.  Use TTE (2D and 3D) to characterize leaflet anatomy and characteristics. Subtypes of TR mechanisms (many times etiology is mixed). Primary: primary leaflet abnormality, occurs in ~10% of cases. Look for prolapse, flail, endocarditis, etc. Secondary/functional: leaflets normal but surrounding structures are abnormal. Atrial: RA and tricuspid annular dilation but normal RV size/shape, and can be related to arrhythmias like atrial fibrillation. Ventricular: RV dilated and/or dysfunctional with leaflet tethering. Can be related to pulmonary hypertension or primary RV disease. Cardiac implantable electronic device (CIED): Related to device (usually pacemakers or ICD) interaction with TV leaflets. Includes perforation, entanglement in subvalvular apparatus, impingement, etc. 3D TTE particularly helpful to evaluate How do we grade TR severity? It is very important to grade the severity of TR, and this is generally done with echocardiography. There are both quantitative and qualitative methods which use Doppler and various equations to estimate TR severity. Current recommendations have expanded TR severity beyond mild/moderate/severe to include “massive” and “torrential” categories. The most important parameters measured/calculated are vena contracta width, regurgitant volume, regurgitant fraction, and effective regurgitant orifice area. Helpful qualitative metrics include hepatic venous flow reversal. When should additional studies beyond transthoracic echocardiography, such as transesophageal echocardiography (TEE), cardiac computed tomography (CT), and cardiac magnetic resonance imaging (MRI) be pursued? TEE is particularly helpful if TTE views are poor. Since TEE is used during transcatheter intervention, a pre-procedure TEE to define anatomy, determine procedure candidacy, and plan for the procedure is critical.  CT is also helpful for procedure planning and has particular strengths in defining annulus size and geometry. A CT is required prior to transcatheter tricuspid valve replacement (TTVR). MRI is helpful for measuring RV volumes and function, but is not generally used to assess TR severity.  What is the approach to the treatment for severe tricuspid regurgitation? The first step is to try to determine the etiology. For secondary TR, treating the underlying condition is indicated. For example, pulmonary vasodilators for pulmonary HTN or guideline therapy for heart failure with reduced ejection fraction. Diuretics are the mainstay for treatment, with the goal to obtain euvolemia. This may require inpatient admission to optimize volume status and medication regimen. Once reversible etiologies are addressed, if the patient is still symptomatic from TR, additional therapies can be considered. What is the role of right heart catheterizations (RHC) in patients with severe TR? RHC is very helpful for many reasons. We use it in TR to help determine volume status, cardiac output, and RV function. Additionally, identifying and characterizing pulmonary hypertension (with pulmonary artery pressures and calculating pulmonary vascular resistance) is an important factor when choosing future therapies.  With severe tricuspid regurgitation, when should we refer for intervention (either with surgery or transcatheter repair or replacement)? Once reversible etiologies are addressed and euvolemia has been achieved, if the patient is still symptomatic from TR despite aggressive medical optimization, additional therapies can be considered. Once euvolemic, a repeat TTE should be ordered to reassess the severity of the TR. Use calculators (for example, either the TRI-SCORE or TRIO score) to predict operative mortality for isolated TR surgery. What are our transcatheter treatment options in severe tricuspid regurgitation, and how do we choose between them? The primary approved transcatheter treatment options for severe TR include transcatheter tricuspid edge-to-edge repair (T-TEER) and transcatheter tricuspid valve replacement (TTVR), of which the Edwards EVOQUE valve is the only one currently approved by the FDA. There are other TTVR device under investigation. These decisions should be made with a multi-disciplinary team including representation from cardiac imaging, interventional cardiology, and cardiothoracic surgery. Factors that go into the decision between T-TEER and TTVR include anatomy (annulus width, coaptation gap, leaflet length), RV reserve, pulmonary hypertension presence, ability to tolerate anticoagulation, patient preference, and institutional experience.  T-TEER is generally the first line with atrial functional and suitable anatomy. It is successful at reducing TR but does not generally eliminate it.  TTVR with EVOQUE is preferred in certain anatomic considerations like a large coaptation gap or when there is CIED-related TR (as this was excluded in T-TEER trials). Patients must be suitable for anticoagulation to receive TTVR as there is risk of leaflet thrombosis without it. If moderate/severe pulmonary hypertension is present, or there is poor RV function, TTVR may be avoided as the sudden elimination of TR causes a sudden increase in RV afterload which may not be tolerated. What is the role in advanced metrics for evaluating RV function? Advanced metrics like RV/PA coupling are under investigation but have not made it into the guidelines. The clinical utility is not yet known.  Assessing the RV function is important as stated above. Dr. Mankad prefers using 3D TTE to calculate an RVEF, or tracking RV longitudinal free wall strain. If you do encounter CIED-related TR, how do you treat it? Evaluate with TTE or TEE. 3D is very helpful to identify relative anatomy and leaflet-device interactions. There is no clear consensus about treatment if CIED-related TR is the primary mechanism of severe TR. If recently implanted, repositioning may be a valid option, but requires discussions with multiple teams including electrophysiology, advanced cardiac imaging, CT surgery, and interventional cardiology. References O’Gara PT, Lindenfeld J, Hahn RT, et al. 10 Issues for the Clinician in Tricuspid Regurgitation Evaluation and Management: 2025 ACC Expert Consensus Decision Pathway. J Am Coll Cardiol. 2025;S0735-1097(25)07047-0. O’Gara PT, Little SH, Badhwar V, et al. Operator and Institutional Recommendations and Requirements for Tricuspid Interventions: 2026 ACC/AHA/ASE/HRS/STS Expert Consensus Systems of Care Document. J Am Coll Cardiol. 2026;S0735-1097(26)05481-1. Hahn RT. Tricuspid Regurgitation. N Engl J Med. 2023;388(20):1876-1891. Davidson LJ, Tang GHL, Ho EC, et al. The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association. Circulation. 2024;149(22):e1223-e1238.

"I wish people understood that the pace of change across this region is not gradual anymore. It's moving very quickly and in many cases faster than traditional global markets expect." Conflicts and disrupted energy flows have put energy security back at the center of the conversation, and Yogaani Bhatia is seeing what that means for geophysics across the Middle East and beyond. Exploration is gaining renewed attention, Saudi Arabia is building out a major mining sector, and countries such as Uzbekistan and Kazakhstan are investing in geological knowledge and new resource development. Behind all of it is the same need: understand the subsurface well enough to make better decisions. And as investment accelerates, the challenge is not simply having better technology. It is having the people who know how to use it. KEY TAKEAWAYS > Energy security is making subsurface knowledge strategic again: Pressure on energy flows is reinforcing the need for secure, diversified resources. Exploration is increasingly viewed not only as a commercial activity, but as a strategic capability tied to long-term energy and resource security. > Some of the fastest change is happening across the Middle East, Central Asia, Africa, and Asia Pacific: Saudi Arabia is expanding mining, Central Asia is investing in geological knowledge, Africa is seeing renewed frontier exploration, and Asia Pacific is advancing offshore energy, CCS, and geothermal. > Energy and minerals draw on many of the same geophysics skills: Imaging, interpretation, data integration, and other subsurface expertise developed in oil and gas are increasingly crossing into mining, critical minerals, geothermal, and carbon storage. > Better technology still depends on people who know how to use it: The AI and digital conversation is shifting from whether the tools have value to how they improve workflows and decisions, while organizations also face a growing need to develop talent and transfer knowledge. THIS EPISODE PROUDLY SPONSORED BY HART ENERGY SUPER DUG Conference & Expo is Hart Energy's premier shale event and the largest event of its kind. If you're looking to stay ahead of what's next in U.S. shale, don't miss the 2026 SUPER DUG, happening September 15-17 in Houston. Join the industry's top operators, executives and investors for three days of market outlooks, strategic discussions and unmatched networking focused on the trends shaping the future of oil and gas. Register today at https://hartenergy.com/SUPERDUG26. Be sure to use promo code SD26-SEG at checkout to save on your registration. Be part of the conversations shaping the future of U.S. shale. LINKS * Find upcoming events at https://seg.org/events. * Read about GEOMIN 2025: A Global Debut in Mining Innovation and Collaboration at https://seg.org/news/geomin-2025-a-global-debut-in-mining-innovation-and-collaboration/. * Learn more about IMAGE '26 and register today at https://www.imageevent.org/. ABOUT SEISMIC SOUNDOFF Seismic Soundoff showcases conversations addressing the challenges of energy, water, and climate. Produced by the Society of Exploration Geophysicists (SEG) and hosted by Andrew Geary of 51 features, these episodes celebrate and inspire the geophysicists of today and tomorrow. Three new episodes monthly. See the full archive at https://seg.org/resources/podcast/.

Learn how AI, 3D imaging, and expert-led education are transforming maternal-fetal medicine. Discover what's new in diagnosing fetal malformations, placental disorders, and complicated twin pregnancies - plus the latest on O-RADS and hybrid CME opportunities. World Class CME City: Charlotte Address: 6201 Fairview Rd. Website: https://worldclasscme.com/

Imaging has traditionally been used to document what (already) happened. What if it could help determine what happens next? On the newest episode of Fractals, Colin Miller is joined by Fidēs Imaging CEO Roughan Sheedy and Head of Women's Health Beth Fisher to discuss how advanced imaging can support earlier, sharper development decisions. They explore:   Why early-phase programs need more than standardized endpoints   How imaging biology in motion can uncover previously invisible phenomena   Where dynamic imaging may add value across GI disease, women's health, fibrosis, inflammation, and solid tumors   What it will take for emerging imaging endpoints to earn regulatory credibility 

Patient out-of-pocket costs can have implications for care access. Jabre Millon, MD, discusses the AJR article by Billig et al. comparing patient cost-sharing for advanced diagnostic imaging in Medicare Advantage plans between 2018 and 2026. Full article: Patient Cost-Sharing for Advanced Diagnostic Imaging in Medicare Advantage Plans Follow AJR on Social Media LinkedIn: https://www.linkedin.com/showcase/ajr-radiology/ YouTube: https://www.youtube.com/channel/UCfFAYezkLMxJGMgIJLN0Dpg Instagram: https://www.instagram.com/ajr_radiology/ TikTok: https://www.tiktok.com/@ajr_radiology X: https://x.com/AJR_Radiology BlueSky: https://bsky.app/profile/ajrradiology.bsky.social

Read the full article at: https://oncdata.com/personalizing-cancer-prevention-ai-enhanced-imaging As healthcare increasingly shifts from reactive treatment to proactive prevention, artificial intelligence (AI) is emerging as a powerful tool for identifying disease earlier and personalizing patient care. In this episode of Exploring AI in Oncology, Dr. Waqas Haque, Hematology/Oncology Fellow at the University of Chicago, spoke with Dr. Sean Raj, Chief Innovation Officer and Chief Medical Officer at SimonMed, about how AI is transforming cancer detection, risk assessment, and patient education. Their conversation highlights how advanced imaging technologies are helping patients gain earlier insights into their health while empowering clinicians with new tools for preventive care.

Jessica Moroux, owner of Acadiana Hyperbarics in Lafayette, joins Discover Lafayette to discuss mild hyperbaric oxygen therapy, the personal experiences that led her to the field, and her belief in giving the body the conditions it needs to heal and function at its best. A Lafayette native, Jessica earned her nursing degree from UL-Lafayette and began her career at Lafayette General, working on several different floors as she searched for the area of nursing that felt like the right fit. Her professional path eventually moved beyond traditional hospital care and into Rolfing, movement therapy, and integrative wellness. Jessica credits some of that outlook to her mother, whom she describes as an early adopter of ideas that today would fall under the umbrella of integrative wellness. Long before probiotics became commonplace, Jessica remembers her mother sprinkling acidophilus on the family's breakfast and taking an unconventional but thoughtful approach to health. As a nurse, Jessica valued traditional medicine and its importance, but found herself increasingly drawn to prevention and helping people maintain their health before they reached the point of hospitalization. “I really wanted to get more into preventative and optimization of health,” Jessica says. “I really wanted to help people stay out of the hospital and feel their best.” Today, Jessica brings together those different disciplines at Acadiana Hyperbarics. A registered nurse and Certified Rolfer, she has an extensive background helping clients address musculoskeletal and sports injuries and chronic pain. A Back Injury, a Child's Concussion, and a New Direction Jessica's interest in hyperbarics was not initially driven by a business plan. It became personal. In 2019, at age 38, she reached for her youngest daughter at an awkward angle and felt a pop and excruciating pain in her back. Imaging revealed a torn disc and two bulging discs. She saw an orthopedist, underwent physical therapy and worked to rehabilitate the injury, but eventually reached a plateau. “I went back to my doctor and said, there's got to be more.” About a year later, the question of what else might be available became even more urgent when Jessica's four-year-old son suffered a serious concussion. Running on a neighbor's all-purpose court, he forgot a tennis net was up, ran into it and was knocked unconscious. Jessica says he experienced short-term amnesia, headaches, irritability and problems with impulse control after the injury. One moment in particular changed the trajectory of her work. “He came in and he had big fat tears rolling down his face and said, ‘Mom, I don't want to have anger issues.'” Jessica remembers thinking, “Okay, we're gonna fix this.” She began researching brain recovery and became interested in hyperbaric therapy. That research eventually grew into a professional focus, particularly around traumatic brain injuries and concussions. Her son, now 12 at the time of our interview, is doing well. “He is doing phenomenally. He's the most charming, intelligent kiddo.” And because, as Jessica laughingly puts it, he remains “wild, all out,” hyperbarics has remained part of the family's approach to recovery from his various sports injuries, including breaking his ankle twice in one year. What Is Mild Hyperbaric Oxygen Therapy? For people familiar with hospital-based hyperbaric chambers, particularly their longtime use for decompression sickness and certain serious wounds, the chamber at Acadiana Hyperbarics looks different. Jessica uses a Vitaeris 320 soft-sided monoplace chamber. According to the clinic, the chamber operates at 1.3 ATA and is 32 inches in diameter and 92 inches long. Acadiana Hyperbarics offers filtered room air as well as an oxygen concentrator option. Jessica describes the experience as similar to the pressure changes you feel on an airplane. During pressurization and depressurization, clients may notice their ears popping or experience sinus pressure. Once the chamber reaches pressure, she says most people largely stop noticing it. Sessions at Acadiana Hyperbarics are offered in 60- and 90-minute increments. Jessica says she screens clients before treatment, asks about their health history and discusses whether the therapy is an appropriate fit for what they hope to accomplish. While people often think hyperbarics is simply about getting a large amount of oxygen, Jessica says pressure is central to the process. Under increased pressure, more oxygen can dissolve into blood plasma, providing an additional route for oxygen delivery beyond oxygen carried by red blood cells. She describes hyperbarics as having several “mechanisms of action,” including angiogenesis, the formation of new blood vessels, as well as effects involving inflammation, collagen, stem cells, mitochondrial function and cellular signaling. For Jessica, the distinction between supporting healing and promising a cure is important. “We are just sending signals and changing some of the physics within the body to let the body do what it does best and to remove some of the barriers.” “Hyperbarics is a fantastic therapy for helping the brains heal and major NFL athletes and teams are now turning to it to help with CTE and concussions.” Why Repetition Matters Jessica explains that some of the effects people experience may be relatively immediate, while tissue repair and other biological processes take time. That is why, depending upon a client's circumstances, hyperbaric therapy may involve a series of sessions rather than a single visit. She also emphasizes the period after a session. Her explanation is that repeated transitions between the higher-oxygen environment associated with treatment and normal atmospheric conditions can stimulate biological responses involved in repair. “If you have multiple exposures, then your body says, okay, this is a real deal. We're going to spend that energy and turn on all those processes.” Jessica's own back injury helped her think about hyperbarics through what she calls “reverse engineering.” She wanted to understand why disc injuries can become chronic and then ask what processes might support healing. Her personal experience with that injury ultimately helped move hyperbarics from something that was “somewhat on my radar” into the focus of a new business. The “Mighty Mitochondria” Our conversation also gets down to the cellular level as Jessica explains mitochondria, the structures within cells responsible for producing ATP, the energy cells use to perform their work. She calls them the “mighty mitochondria.” “For any function within the body, you have to pay for it, right? You have to have a currency. For a car to drive, you've got to have fuel. Same thing with your cells.” That cellular energy is one reason oxygen is so important. Jessica also points to exercise as a way to support mitochondrial function and discusses red and infrared light therapy, another modality offered at Acadiana Hyperbarics. The clinic uses red and infrared light pads that can be placed around targeted areas of the body. Jessica says she likes the flexibility of pads because they can conform around an injured shoulder, back or other area rather than requiring the client to lie on a rigid light bed. Acadiana Hyperbarics describes its low-level light therapy as a complementary modality that can be used alongside hyperbaric sessions. The Vagus Nerve, Stress, and the Need to Recover One of the most relatable parts of our conversation concerns something many of us experience every day: living in a near-constant state of stimulation. Jessica explains the role of the vagus nerve and the balance between the sympathetic “fight or flight” response and the parasympathetic “rest and digest” state. “When you're in fight or flight mode, you're not repairing well,” Jessica says. “Most of us are running around constantly stimulated, answering emails, in traffic, fussing at your kid.” The problem, she says, is that we may never adequately switch into recovery mode. “You can't heal if you're not getting into that mode of recovery.” Supporting the vagus nerve doesn't necessarily require sophisticated technology. Jessica points to simple practices including humming and breathwork as ways people can encourage the body to shift toward a calmer state. Training and Knowing What You're Getting Jessica completed training through the International Hyperbarics Association and is a member of the organization. She says she attends its conference and continuing education programs each year. That training is particularly important to her as hyperbarics and other wellness therapies become more popular. “As the wellness industry is growing and booming and this therapy is catching on, there's a lot of providers who are wanting to throw it in as an afterthought.” Jessica describes the therapy as generally safe when appropriately used, but stresses that providers need to understand screening, protocols and how to apply the therapy appropriately for an individual client. “More than causing further damage, you could just not apply the therapy correctly and the patient may not get what they're looking for when paying for the treatment.” Acadiana Hyperbarics' own guidance also stresses client screening and identifies medical circumstances that require particular attention.. Anyone considering hyperbaric therapy for a medical condition should discuss it with an appropriate healthcare professional. From Hospital Medicine to Wellness Hyperbaric medicine has long been associated with conditions such as decompression sickness, the “bends” experienced by divers who surface too quickly, as well as certain serious wounds and other medical conditions. Those original hospital chambers looked much different from today's soft-sided mild hyperbaric chamber utililzed at Jessica's practice. Our conversation explores the difference between those hospital applications and the wellness-oriented, largely off-label uses Jessica works with today. She is careful to characterize hyperbarics as an adjunct rather than a replacement for appropriate medical treatment. She also acknowledges that timing matters and that not every condition or individual is a good candidate. “For some people, if the injury is too far gone, it may not be a good fit.” That is why her process begins with a conversation rather than simply putting someone into a chamber. Life Beyond the Chamber When she isn't working, Jessica's life revolves around her family, music and travel. She and her husband are both musicians and enjoy Lafayette's local music scene. Jessica has played violin since childhood, thanks to a mother who essentially told her quitting wasn't an option. “My mom started me when I was little and she kind of was like, ‘You're not quitting, so get used to it.'” She performed in orchestra during college and played events, although these days, between running a business and raising three children, performances are more likely to happen at home. “Right now with the business and the kiddos, it's mostly in the living room with the family.” Jessica's journey from nursing to Rolfing and ultimately Acadiana Hyperbarics has been driven by curiosity, personal experience and a desire to help people think about wellness before something is seriously wrong. Her message is not simply about addressing an injury. It is about recovery, maintaining function and giving the body the support it needs while you are still feeling well. Acadiana Hyperbarics is located at 708 E. University Avenue in Lafayette. Learn more about Jessica, mild hyperbaric oxygen therapy, Rolfing and the other services she offers at https://acadianahyperbarics.com/.

In this episode, host Dr. Nick Rainey is joined by Dr. Bremen Abuhl and Dr. Dallas Ehrmantraut to discuss their 2025 Physical Therapy Journal article, “First Contact Physical Therapy Compared to Usual Primary Care for Musculoskeletal Disorders: A Systematic Review and Meta-Analysis of RCTs.”The conversation explores whether physical therapists should serve as the first point of contact for patients with musculoskeletal disorders and how first contact PT compares with usual primary care.Dr. Abuhl and Dr. Ehrmantraut discuss their findings, including reduced imaging utilization, reduced prescription medication utilization, and similar clinical outcomes for pain, disability, and health-related quality of life. They also unpack the terminology around direct access, first contact PT, and primary care PT, and explain why direct triage models may offer a more efficient pathway for patients.The episode also addresses real-world implementation barriers, including reimbursement models, state scope-of-practice variation, imaging privileges, medication prescribing, stakeholder buy-in, and the need for PTs to step confidently into first contact roles.Key TakeawaysFirst contact PT is not the same as direct access. Direct access means patients can choose PT without referral. First contact PT means the PT is the first provider evaluating the patient for that episode of care.The study found lower healthcare utilization. First contact PT was associated with 45% less imaging and 71% less prescription medication utilization compared with usual primary care.Clinical outcomes were similar. Pain, disability, and health-related quality of life outcomes were statistically similar between first contact PT and usual primary care.Less imaging is not automatically the goal. The more important question is appropriate utilization: avoiding both overuse and underuse.Implementation is a system problem. Scope of practice, reimbursement, stakeholder buy-in, state law, and health system workflows all influence whether first contact PT can work.Direct triage may be the stronger model. Compared with warm handoffs, direct triage allows patients with appropriate MSK presentations to start with PT as the first provider.PTs need to be ready for real-world first contact care. That includes identifying red flags, determining urgency, ordering or recommending imaging when appropriate, and referring to the right provider when needed. Chapters: 00:00 — Welcome and guest introductions 01:17 — Dr. Bremen Abuhl's path into first contact PT research 03:13 — Dr. Dallas Ehrmantraut's clinical spark for the topic 06:16 — Overview of the PTJ systematic review and meta-analysis 09:52 — Direct access vs first contact PT vs primary care PT 13:15 — Global evidence and limited U.S.-based RCTs 16:24 — Imaging findings and appropriate utilization 20:37 — Medication utilization findings 23:27 — Clinical outcomes: pain, disability, and quality of life 25:20 — Study limitations and downstream utilization 27:13 — Why longer-term outcomes matter 31:15 — Risk of bias and crossover between groups 33:36 — U.S. system barriers to first contact PT 36:37 — Reimbursement, payer models, and stakeholder concerns 40:45 — Direct triage vs warm handoff models 44:15 — Scope of practice and state-level barriers 46:08 — Real-world safety, red flags, and PT decision-making 48:01 — Call to action for physical therapists 50:06 — Closing thoughts

WELCOME BAAAACK to The Astrocast! Roo sits down this week for a quick catch up with you guys to discuss his next project, and the ongoing NONSENSE that is Reflect Orbital. This one gets a little spicy, fair warning!!! Read the FCC Petition from AAS here.  CALL OR WRITE YOUR LOCAL POLITICIANS! MAKE them do SOMETHING! Join our Patreon, and get access to the BEST community in AP!: https://www.patreon.com/c/TheAstrocast

In this episode, Seth sits down with Jess Ellis, fellowship-trained physical therapist, former NBA health and performance leader, founder of Rehab Code, and consultant for professional athletes.Jess shares his career path from early burnout in high-volume physical therapy to mentorship with Tim Fearon, fellowship training, EXOS, the Portland Trail Blazers, the New York Knicks, and his current work in mentorship, consulting, and concierge care.The conversation explores the realities of working in professional sports, including the pressure of return-to-play decisions, reduced clinical autonomy, team politics, athlete relationships, and the lifestyle tradeoffs that come with elite sport. Jess also discusses his PhD work on athlete buy-in with wearable technology and force plate testing, raising important questions about trust, data, ethics, and shared decision-making.This episode also gets into the deeper professional questions many PTs face: Are you actually getting better? Are you pursuing mastery or professional FOMO? Are you being clinically honest with yourself and your patients? And are you relying on theory, or producing meaningful change?A sharp, candid conversation for clinicians interested in OMPT, sports rehab, mentorship, career development, and pragmatic clinical reasoning.Chapters: 00:00 — Welcome and Jess Ellis intro01:34 — Burnout, mentorship, and fellowship training03:00 — EXOS, NBA roles, and Rehab Code06:23 — Career growth and owning your opportunities09:11 — OMPT in pro sports11:01 — Imaging, structure, and pathomechanics12:55 — Why fellowship changed Jess's reasoning14:54 — The reality of working in pro sports17:01 — Return-to-play pressure18:08 — Leadership, politics, and athlete trust20:10 — Lifers, burnout, and leaving sport23:43 — Athlete data, wearables, and Jess's PhD27:50 — Clinical bias and shared decision-making30:00 — Pain science communication problems31:43 — Mentorship and PT career paths34:15 — Professional FOMO vs mastery35:54 — Clinical honesty and getting better37:47 — Pragmatism, listening, and results40:11 — Where to find Jess Ellis

Commentary by Dr. Zhenjie Liu.

Dr. Maya Patel and Dr. Tetyana Gorbachova explore key vascular variants of the upper and lower extremities that radiologists may encounter on routine musculoskeletal imaging, highlighting how to recognize them and understand their clinical significance. They discuss the surgical implications of variants such as the persistent median artery, corona mortis, persistent sciatic artery, and aberrant anterior tibial artery, emphasizing how accurate identification can help prevent serious complications including neuropathy, hemorrhage, limb ischemia, and amputation. Charting Variant Vascular Pathways in Musculoskeletal Imaging: Clinical and Surgical Implications. Patel et al. RadioGraphics 2026; 46(3):e250073. 

King and I | S6 E9 | Should Recent Clinical Evidence Change How We Use Intravascular Imaging–Guided PCI

Ep 128: Erik Mello of Mello Imaging Technologies joins the boys to talk about the importance of having a rep that you can reach out to for help with your projects, from getting the right materials to knowing how to properly use them, and more.Get the offer from Geneva Capital: No Payment for 90 Days, Zero DownCheck out the featured products:Arlon DPF V9500G2G ProductsMetamark"Your podcast is the best podcast in the business." - Jared Granberry, President, GSG (Graphic Solutions Group)The Slightly Serious Sign Podcast is now the #1 Most Fact Checked Podcast in the United States.Voted #1 by Signman (standing on a van on top of 18 pallets changing a lightbulb over a movie theater sign)https://www.wensco.com/company/slightly-serious-sign-podcast616.785.3333W.A.R. (Wensco Automotive Restyling)Slightly Serious Sign Podcast Theme Song Courtesy of Joe Morreale© 2025 Joe MorrealeThe views, thoughts, and opinions expressed are the speaker's own and do not represent the views, thoughts, and opinions of Wensco Sign Supply. The material and information presented here is for general information purposes only. The "Wensco Sign Supply" name and all forms and abbreviations are the property of its owner and its use does not imply endorsement of ...

Program notes:0:44 Novel agent for acute pain1:44 Post-abdominal surgery and placebo, low and high dose2:46 Compared to placebo and opioids3:19 Metabolic associated steatotic liver disease4:19 Imaging with two techniques and plasma markers5:19 Imaging and composite scores for staging6:21 Identifying appropriate candidates for clinical trials7:00 Alcohol consumption during pregnancy8:00 Employed, tobacco use, and mental stress predicts9:01 Never tested medicines for AUD in pregnant women9:24 Early detection of Alzheimer's disease with circular RNA10:24 Can it identify those with the disease as well as those at risk11:24 Almost 95% AUC12:20 Use with tau, it was even better13:05 End

**YOUTUBE VERSION HERE!!!*** - you'll wanna see this!How big does another galaxy look with the naked eye? In Chile's Atacama Desert, Nico Carver saw the Large Magellanic Cloud hanging in the sky—so large that members of his group initially thought it was an ordinary cloud!Welcome BACK to The Astrocast! Roo sits down with Nico Carver of Nebula Photos to discuss his Atacama astrophotography workshop, the Southern Milky Way, 3D-printed astro gear, AI, smart scopes, remote observatories, mono versus one-shot color and much more. We also explore Nico's incredible images of Gamma Velorum, the Vela Supernova Remnant, the LMC, Corona Australis and the Southern Cross-to-Carina region.Thank you to Nico for being such a wonderful friend of the show!

Discover how the 2026 CMS rule permanently allowing virtual direct supervision is helping outpatient imaging centers navigate the radiologist shortage. Learn about compliance requirements, operational benefits, and strategic solutions to keep your facility running smoothly. Visit https://www.contrast-connect.com/pricing ContrastConnect City: Las Vegas Address: Las vegas Website: https://www.contrast-connect.com/

In this episode of the Rehab Science Podcast, Dr. Tom Walters discusses one of the most common causes of neck pain that radiates into the shoulder and arm: cervical radiculopathy. Using a real patient case, Dr. Walters explains how recurring neck tension and intermittent arm tingling ultimately led to the diagnosis of a C5-C6 disc herniation with narrowing of the intervertebral foramen. More importantly, he discusses why MRI findings are only one piece of the diagnostic puzzle and why many people have disc bulges and herniations without experiencing any symptoms. You'll learn how cervical disc herniations can irritate nearby nerve roots, the anatomy and biomechanics of the cervical spine, and why a thorough history and physical examination are just as important as imaging when determining the source of a person's symptoms. The episode also covers evidence-based rehabilitation strategies, including cervical mobility, thoracic mobility, shoulder mobility, deep neck strengthening, and nerve mobilization exercises. Finally, Dr. Walters reviews common medical management options, including medications, epidural steroid injections, and when surgery may be appropriate. In This Episode What cervical radiculopathy is and why it develops A real patient case involving a C5-C6 disc herniation The anatomy and biomechanics of the cervical spine Why MRI findings don't always correlate with symptoms The difference between treating an MRI and treating the patient Evidence-based rehabilitation principles Medical management options, including medications, injections, and surgery When to seek further medical evaluation Key Takeaway A cervical disc bulge or herniation does not automatically explain your symptoms. Imaging should always be interpreted alongside your history, physical examination, and neurological findings. For many people, a comprehensive rehabilitation program focused on restoring mobility, strength, and nerve function can significantly reduce symptoms and improve quality of life. Resources YouTube Video Link Rehab Science Book Link Rehab Science App Link

This election season is bringing a major hike in ad rates. What's a lawyer to do? Later, service and gifts give every member of your law firm the opportunity to level up client experiences.  ----- Massive political ad spends are pushing expenses higher than ever in the lead-up to November 6, impacting your branded advertising economics both online and off. Do you need to make changes to your firm's marketing campaigns? Should you take a break from branded advertising or push through? Conrad and Gyi debate tactical options to help you make informed decisions with your advertising budget.  And, if you do decide to cut back on digital media buys, where are those extra marketing dollars going to go? A gift budget is an excellent way to help your team members get involved in marketing. The guys explain how gifting promotes a more thoughtful mindset, helping your team connect more deeply with clients and creating opportunities to build affinity for your law firm.    The News: Depending on where you're located—Elections advertising spend for 2026 expected to reach record high, outpacing presidential years.  Local positioning in action, folks: Michigan roofer bets on community over private equity. Imaging running a carefully worded ad just to have an AI summary screw it all up. Thanks, Google…bleh. – Google tests AI-generated summaries in Search ads And, here's a real life example from Darcy Burk. Shout out to Michigan Auto Law for this cool campaign: Get Up To $3,000 Free. How do we teach young lawyers to function in an AI world without relying on AI in the learning process? – UChicago Law Unveils New AI Strategy   Make Summer More Fun:  Come see us in Nashville 8/11-8/13 at the LHLM Super Summit! Listen Next: Mindful Gifting || Resolutions Past and Future Connect: Leave Us an Apple Review  Lunch Hour Legal Marketing on YouTube  Lunch Hour Legal Marketing on TikTok r/LHLM  Subscribe to Lunch Hour Legal Marketing: https://play.megaphone.fm/boagdxq4tr2wawseaj104w In This Episode 00:00 Intro & The Trophy Story 03:05 News: Election Ad Spend Record Highs 03:40 News: Local Positioning Lessons from a Roofer 05:35 News: Google Testing AI Summaries in Ads 06:19 News: Michigan Auto Law Campaign Shout-out 07:13 News: UChicago Law's New AI Strategy 09:43 Should Lawyers Pause Ads During Mid-terms? 11:15 Strategy: Location-Specific Ad Planning 13:16 The Debate: Branding Consistency vs. Ad Spend 15:52 Direct Response vs. Brand Awareness 23:18 Employee Gifting Programs for Law Firms 27:10 Logistics: Using Gifting Platforms 28:32 The Power of Personalized Client Gifts 31:40 Incentivizing Employee Engagement 34:10 Operationalizing Marketing Efforts 38:34 Aligning Firm Growth with Staff Goals

This month, we start with a systematic review on smart ways to cut down unnecessary X-rays in kids with limb injuries. We also look at why subarachnoid haemorrhages get missed or diagnosed late, from both patient and doctor perspectives. A Best Evidence Topic (BET) review asks if simple haematoma blocks are as good as procedural sedation for resetting broken wrists. And finally, we dive into a UK study exploring what life is really like for early-career academic doctors in emergency care. Read the highlights: Primary survey (https://emj.bmj.com/content/43/7) Interventions to reduce imaging in children with upper or lower extremity injuries: a systematic review and meta-analysis  (https://emj.bmj.com/content/43/7/435) Prospective patient-reported reasons for delayed diagnosis of spontaneous subarachnoid haemorrhage (https://emj.bmj.com/content/43/7/390) Haematoma block versus sedation for manipulating distal radius fractures in the emergency department (https://emj.bmj.com/content/43/7/448) Balancing act of academic clinical fellows in UK emergency medicine: a qualitative study  (https://emj.bmj.com/content/43/7/419) The EMJ podcast is hosted by: Prof. Richard Body, EMJ Editor-in-Chief, University of Manchester, UK (@richardbody) Dr. Sarah Edwards, EMJ Senior Associate Editor and Social Media Editor, Royal Derby Hospital, UK (@drsarahedwards) You can subscribe to the EMJ podcast on all podcast platforms to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast Apple (https://apple.co/4bfcMU0) or Spotify (https://spoti.fi/3ufutSL) page.  

Meetings don't consume time. They create leverage. The moment a business begins to grow, the doctor faces a choice: remain the person solving every problem or become the leader who develops people capable of solving them. That transition rarely happens by accident, and it often reveals itself in the way meetings are run.  In this episode, Dr. Stephen and Dr. Pete unpack the Millionaire Meeting Framework, a seven-step process designed to transform meetings from routine conversations into high-leverage opportunities for alignment, accountability, leadership development, and execution. From creating clarity around PRIORITY to empowering team members to think critically and bring solutions instead of problems, this episode provides a practical roadmap for moving beyond owner-operator thinking and building a business that can grow through people rather than depend on them.In This Episode You Will Discover:  Why the most valuable meetings often start with a question most leaders skip  The hidden reason smart teams continue solving the wrong problems  A framework that develops leaders instead of creating more dependence  How one simple question can completely change the quality of team conversations  The difference between a meeting that consumes time and one that creates leverage   Episode Highlights 02:10 - Meetings don't consume time. They create leverage, and the best leaders know how to multiply their impact through them.  05:17 - The fastest leaders aren't the ones who rush meetings. They're the ones who bring a framework.  07:14 - Question 1: How are you doing? A one-minute check-in sets the tone before the business begins.  08:20 - Question 2: What is our priority? Every great meeting starts by identifying the one constraint that matters most.  11:28 - Question 3: What is the objective of this meeting? Clarify the problem before trying to solve it.  15:08 - Question 4: What is your 1-3-1? Great leaders don't collect problems. They develop critical thinkers.  18:41 - Question 5: How can I help you? Support replaces rescue when a leader chooses coaching over taking ownership of every task.  20:47 - Question 6: Do we have a solution? Alignment happens when expectations become clear agreements.  21:02 - Question 7: What is your takeaway? Every meeting ends with do what, by whom, and by when. 21:45 - Imaging technology is evolving rapidly, and chiropractors have more opportunities than ever to improve efficiency and patient care. Dr. Pete sits down with J.R. Marsee from Success Partner Blue Ridge Imaging to explore turnkey imaging solutions, ongoing support, and the growing role of AI in modern chiropractic practices. Together, they discuss how the right technology partner can help practices operate with greater confidence today while preparing for the future.   Resources Mentioned To learn more about the REM CEO Program, please visit:  http://www.theremarkablepractice.com/rem-ceo For more information about Blue Ridge Imaging please visit: https://blueridgeimagingtechnologies.com Book a Strategy Session with Dr. Pete - https://go.oncehub.com/PodcastPC Prefer to watch? Catch the podcast on YouTube at: https://www.youtube.com/@TheRemarkablePractice1 To listen to more episodes, visit https://theremarkablepractice.com/podcast or follow on your favorite podcast app.

Michalis Papadakis, CEO and Co-Founder of Brainomix, is developing AI technology to automate the analysis of brain scans of stroke patients, addressing the critical clinical gap where a majority of patients who should receive treatment are not being identified. The platform identifies stroke location, blocked vessels, and at-risk brain tissue on CT scans, enabling faster diagnosis and treatment decisions by a broader range of front-line clinicians who may lack stroke care expertise. In a large-scale evaluation, Brainomix demonstrated that it can save an hour in reaching treatment decisions and dramatically increase the number of patients who achieve full recovery. Michalis explains, "Brainomix started quite a few years ago now, and, as you noted, I'm one of the founders. And back then, I was the scientific director of the preclinical stroke lab at the University of Oxford here in the UK, doing research in stroke. And together with the other founders, what made us establish Brainomix and create Brainomix as a spinoff from the university was starting with the clinical unmet need. "As we were all experts in stroke, we knew that stroke is a devastating disease. It ages the brain by 3.6 years every hour a patient remains untreated. And although we have lifesaving treatments, up to 80% of patients who should be treated are missing out. And when we created Brainomix, we knew that imaging, which means the interpretation of the brain scan of patients who have strokes, is a barrier that is leading directly to this big number of patients missing out on being selected for treatment." "The idea was that if we used the AI and automated the analysis of the brain scans of those patients, we could help frontline clinicians with diagnosis and treatment decisions. So, since we started, we have been developing a technology that aims to increase the uptake of existing treatments in clinical care, but we are also working with pharma companies and biotech companies that are developing new treatments to increase the success of the trials." #Brainomix #Brainomix360Stroke #StrokeCare #AcuteStroke #StrokeTreatment #Neurology #MedicalImaging #ImagingAI #AIinHealthcare #DigitialHealth #HealthcareInnovation #Neuroradiology #PatientOutcomes #Thrombectomy #DigitalHealth #ClinicalDecisionSupport brainomix.com Listen to the podcast here

Michalis Papadakis, CEO and Co-Founder of Brainomix, is developing AI technology to automate the analysis of brain scans of stroke patients, addressing the critical clinical gap where a majority of patients who should receive treatment are not being identified. The platform identifies stroke location, blocked vessels, and at-risk brain tissue on CT scans, enabling faster diagnosis and treatment decisions by a broader range of front-line clinicians who may lack stroke care expertise. In a large-scale evaluation, Brainomix demonstrated that it can save an hour in reaching treatment decisions and dramatically increase the number of patients who achieve full recovery. Michalis explains, "Brainomix started quite a few years ago now, and, as you noted, I'm one of the founders. And back then, I was the scientific director of the preclinical stroke lab at the University of Oxford here in the UK, doing research in stroke. And together with the other founders, what made us establish Brainomix and create Brainomix as a spinoff from the university was starting with the clinical unmet need. "As we were all experts in stroke, we knew that stroke is a devastating disease. It ages the brain by 3.6 years every hour a patient remains untreated. And although we have lifesaving treatments, up to 80% of patients who should be treated are missing out. And when we created Brainomix, we knew that imaging, which means the interpretation of the brain scan of patients who have strokes, is a barrier that is leading directly to this big number of patients missing out on being selected for treatment." "The idea was that if we used the AI and automated the analysis of the brain scans of those patients, we could help frontline clinicians with diagnosis and treatment decisions. So, since we started, we have been developing a technology that aims to increase the uptake of existing treatments in clinical care, but we are also working with pharma companies and biotech companies that are developing new treatments to increase the success of the trials." #Brainomix #Brainomix360Stroke #StrokeCare #AcuteStroke #StrokeTreatment #Neurology #MedicalImaging #ImagingAI #AIinHealthcare #DigitialHealth #HealthcareInnovation #Neuroradiology #PatientOutcomes #Thrombectomy #DigitalHealth #ClinicalDecisionSupport brainomix.com Download the transcript here

This election season is bringing a major hike in ad rates. What's a lawyer to do? Later, service and gifts give every member of your law firm the opportunity to level up client experiences.  ----- Massive political ad spends are pushing expenses higher than ever in the lead-up to November 6, impacting your branded advertising economics both online and off. Do you need to make changes to your firm's marketing campaigns? Should you take a break from branded advertising or push through? Conrad and Gyi debate tactical options to help you make informed decisions with your advertising budget.  And, if you do decide to cut back on digital media buys, where are those extra marketing dollars going to go? A gift budget is an excellent way to help your team members get involved in marketing. The guys explain how gifting promotes a more thoughtful mindset, helping your team connect more deeply with clients and creating opportunities to build affinity for your law firm.    The News: Depending on where you're located—Elections advertising spend for 2026 expected to reach record high, outpacing presidential years.  Local positioning in action, folks: Michigan roofer bets on community over private equity. Imaging running a carefully worded ad just to have an AI summary screw it all up. Thanks, Google…bleh. – Google tests AI-generated summaries in Search ads And, here's a real life example from Darcy Burk. Shout out to Michigan Auto Law for this cool campaign: Get Up To $3,000 Free. How do we teach young lawyers to function in an AI world without relying on AI in the learning process? – UChicago Law Unveils New AI Strategy   Make Summer More Fun:  Come see us in Nashville 8/11-8/13 at the LHLM Super Summit! Listen Next: Mindful Gifting || Resolutions Past and Future Connect: Leave Us an Apple Review  Lunch Hour Legal Marketing on YouTube  Lunch Hour Legal Marketing on TikTok r/LHLM  In This Episode 00:00 Intro & The Trophy Story 03:05 News: Election Ad Spend Record Highs 03:40 News: Local Positioning Lessons from a Roofer 05:35 News: Google Testing AI Summaries in Ads 06:19 News: Michigan Auto Law Campaign Shout-out 07:13 News: UChicago Law's New AI Strategy 09:43 Should Lawyers Pause Ads During Mid-terms? 11:15 Strategy: Location-Specific Ad Planning 13:16 The Debate: Branding Consistency vs. Ad Spend 15:52 Direct Response vs. Brand Awareness 23:18 Employee Gifting Programs for Law Firms 27:10 Logistics: Using Gifting Platforms 28:32 The Power of Personalized Client Gifts 31:40 Incentivizing Employee Engagement 34:10 Operationalizing Marketing Efforts 38:34 Aligning Firm Growth with Staff Goals

Micro-X's patented X-ray technology is smaller, lighter, faster and more precise than anything the world has seen before, creating new opportunities for industries. The company, based at the Tonsley Innovation District in Adelaide, has developed a mobile X-ray platform manufactured in Australia and sold around the world. Now it is using this lightweight tech to create the world's first portable stroke head CT scanner, small enough to fit in an ambulance or retrieval aircraft using precise imaging to diagnose stroke patients before reaching hospital, giving patients access to treatment sooner and increasing their chances of survival. Micro-X Chief Executive Officer Kingsley Hall and Chief Operating Officer Anthony Skeats join AUScelerate's Caroline Duell and Dana Bell to discuss the company's trajectory that led to the development of their life-saving diagnostic platform using unconventional carbon nanotubes. 

Are you maximizing early breast cancer detection in high-risk patients? Learn why traditional screening may not be enough. Credit available for this activity expires: 7/21/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/optimizing-breast-mri-surveillance-high-risk-patients-2026a1000nau?ecd=bdc_podcast_libsyn_mscpedu

How should prostate biopsy be performed in the MRI era, and what impact does biopsy strategy have on treatment planning?In this episode, Prof. Francesco Sanguedolce is joined by Prof. Francesco Giganti, Prof. Gianluca Giannarini and Prof. Lars Budäus to discuss the latest expert recommendations on prostate biopsy.The conversation explores the importance of high-quality MRI, targeted and perilesional biopsy strategies, the role of emerging imaging technologies and the ongoing debate surrounding systematic biopsy.The faculty also discuss how biopsy findings can influence decisions on focal therapy, nerve-sparing surgery and lymph node dissection, while highlighting current areas of consensus and the questions that still remain in clinical practice.ProBIOPSY: A Multidisciplinary International Consensus on Standards for Prostate Biopsy, European Urology, article in press. Doi.org/10.1016/j.eururo.2026.06.012)This podcast is brought to you in collaboration with the EAU Section of Urological Imaging.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

   ✨ Agena Astro |

Alternate Recording: Equipping Hour | Imaging God in a Broken World | Sex and Gender (2) by OrlandoGrace

This webinar explores the evolving role of imaging in the diagnosis and management of gout. Our expert panel will discuss when and how to use ultrasound, dual-energy CT (DECT), crystal identification, and conventional radiography, while addressing practical questions such as the role of imaging in diagnostic uncertainty, serial disease monitoring, and whether ultrasound is changing the need for synovial fluid analysis in everyday practice. Panelists: Dr. Nicola Dalbeth Dr. John Fitzgerald Dr. Sarah Tedeschi Dr. Jack Cush (moderator)

Dr. Mahmud Mossa-Basha joins Dr. K to discuss contrast utilization and iodine stewardship in CT and MR imaging, highlighting lessons from the 2022 contrast shortage, strategies for optimizing contrast use, and the role of emerging technologies in supporting high-quality patient care. Claim your Credit Here This MR iCast episode is supported by Bracco Diagnostics Inc. through an unrestricted educational grant.

Group A strep in the pediatric ED: from strep throat to invasive disease and toxic shock. Host: Ellen Duncan, MD, PhD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Group_A_Strep.mp3 Download Leave a Comment Tags: Infectious Diseases, Pediatrics Show Notes Background Group A strep = Streptococcus pyogenes — gram-positive organism that colonizes the pharynx, but also the perianal and genital mucosa (worth remembering when the source isn’t the throat). Extremely common. The episode cites an estimated ~289 million cases/yr of strep pharyngitis in children 5–14 (NIH). For a U.S.-specific, verifiable anchor: the CDC estimates strep throat drives ~5.2 million outpatient visits/yr in people

The Making Of Evelina Smiles - SIXDelays, Profit Sharing, and the Week Before Everything ChangesIn this episode Ashley sits down with Dr. Rich Constantine for a look at what the final stretch before a soft opening actually feels like. Setbacks, systems, 300 patients on a priority list, and the first peek at how Rich thinks about rewarding his team.What You'll Hear in This Episode:The Weeks Leading Up to Opening Supplies delayed by the Fourth of July holiday. Design Ergonomics trainer flew in but not everything was ready. Certificate of occupancy and zoning permit still pending over a landscaping detail. How Rich is keeping his head right when things do not go as planned. His mantra this week: pressure is a privilege.Where the Building Stands Software integrated. Imaging bridged with practice management. Phones hooked up. Wi-Fi working. TVs up. Chandeliers hung. Interior signage still coming. Half the waiting room furniture arrived. Scanner still in transit. Soft open pushed back.Training and Systems CareStack boot camps underway. Admin team working through UCR fees, third party financing conversations, patient portals, and building out Q and A for the AI phone system. Say this not that verbiage in place for both front desk and clinical team. Written playbooks and binders being built from scratch before the first patient walks in.300 Patients on the Priority List Rich casually drops one of the biggest wins of the episode. How the landing page, social media, QR code signage, and periodic email updates built a pipeline of 300 prospective patients before the doors even open. What he is doing first when the phones go live and why he is keeping ad spend light to start so he can see what is actually working.Merch, Giveaways, and Branded Everything The T-shirt rabbit hole. Why Rich wants to do premium branded gear or nothing at all. Printful, Real Thread, BYLT, and Cuts all come up. Ashley makes the case for buying great shirts and just getting them embroidered locally.Profit Sharing vs Bonus Culture Rich opens up about how he thinks about rewarding his team. Why he calls it profit sharing and not a bonus. Clear KPIs, collective rewards, and why nobody gets money that is not there. The difference between rewarding people blindly and building a team that understands the numbers. And why you do not own a business if you have to be there for it to run.Connect with Ashley: Instagram: @ashleyjovesddsConnect with Rich: Instagram @dr.c_smiles or richconstantinedds@gmail.comThank You to Our PartnersNet32: The dental marketplace that helps practice owners stop overpaying for supplies. Compare and save at net32.com/themakingof.Studio 8E8 — Dentistry's story-driven growth agency for startups. s8e8.com/vslKasper Opportunity Finder: Fill those empty chairs and reclaim lost revenue with one click. Get it free at meetkasper.com/register.Support the showFind Out MoreThank you for listening to The Making Of podcast. If you enjoyed it, please share with anyone you think will gain value from the show by clicking on one of the sharing tabs above.SUBSCRIBE to our NEWSLETTER HEREAlso, please consider leaving an honest review on iTunes. It helps other listeners find the show, and I would be forever grateful.Questions or comments? Feel free to contact us at - themakingofadental@gmail.comFollow us on Instagram or Facebook and improve your dental practice every day!Have you subscribed? Don't miss a single episode!

Endometriosis care is about so much more than surgery.In this episode, Nicole sits down with endometriosis excision surgeon Dr. Mallory Stuparich for a wide-ranging conversation on what it really takes to care for patients living with endometriosis.We discuss: The role of pelvic PT before and after surgery  Setting realistic expectations for recovery  Central sensitization and persistent pain  Imaging, inflammation, and recurrence  Why multidisciplinary care leads to better outcomes But one message stood above everything else:Our first job is to rebuild trust.Many patients with endometriosis have spent years feeling dismissed, misunderstood, or told their symptoms were normal. Before we can guide them toward healing, we have to help them feel seen, heard, and believed.Whether you're part of the surgical team or the rehabilitation team, that trust is where recovery begins. About Dr. Mallory StuparichDr. Mallory Stuparich is a fellowship-trained gynecologic surgeon specializing in advanced endometriosis excision surgery, adenomyosis, and complex pelvic pain. She is passionate about collaborative care and helping patients navigate every stage of their treatment journey with compassion, education, and evidence-based care.Downtraining MasterclassHelping patients with persistent pelvic pain requires more than great hands-on skills.Our Downtraining Masterclass provides practical frameworks for treating high-tension, pain-dominant patients with more confidence.

Johannes Galatsanos occupies an unusual dual perch in the quantum ecosystem. As a co-author of the inaugural MIT Quantum Index Report, he's helped map the entire quantum landscape at altitude; as co-founder and CEO of Diffraqtion, he's staked his career on one of its most under-discussed corners: quantum imaging. The company spun out of Saikat Guha's lab at the University of Maryland after more than a decade of DARPA-funded research, emerged from stealth in January 2026 with $4.2M in pre-seed funding, and is now racing toward on-sky telescope demonstrations and a 2028 satellite launch.This episode is for listeners who want a technically honest look at where the "quantum" label is doing real work in a sensor versus where it's shading into sophisticated photonics and analog computing. If you care about how quantum technologies actually reach the world — through markets, contracts, and hardware that ships — this conversation gives you a specific, concrete example to think with.What You'll LearnWhy a conventional camera can lose roughly 95% of the information a photon carries, and what quantum Fisher information theory says about recovering itHow Diffraqtion's device processes light directly in the photonic domain before converting it to electronic information — and why that matters for shot noiseThe honest answer to "is this really quantum?" — including where the technology sits between quantum information theory, photonics, and analog computingWhy a 6U CubeSat with a 10-centimeter aperture can plausibly compete with school-bus-sized observation satellites for specific tasksHow a "diffractive neural network" runs image classification at the speed of light with negligible power consumptionThe difference between Diffraqtion's hard-coded Gen 1 camera and the reprogrammable Gen 2 that can swap algorithms in orbit (canopy detection over the Amazon, ship detection over the Atlantic)Why the Habitable Worlds Observatory needs a coronagraph capability — and how you can build one by processing light rather than blocking itWhat quantum sensing needs from policy, capital, and PR to escape the shadow of quantum computingResources & LinksGuest & CompanyDiffraqtion — Company homepage; describes the technology, NASA/DARPA lineage, and the "quantum eye" framing referenced in the conversation.Johannes Galatsanos on LinkedIn — Recent activity including SmallSat Europe, the NASA Space to Soil Challenge, and GQIG Summit talks on quantum imaging.Papers & ReportsQuantum Index Report 2025 (arXiv) — The preprint of the MIT QIR, co-authored by Galatsanos. Essential reading for anyone trying to see the quantum landscape as a whole.MIT Sloan — New MIT Report Captures State of Quantum Computing — Background on the QIR and Galatsanos's research role at the MIT Initiative on the Digital Economy.MIT Sloan — Quantum Report Charts Growing Business Interest — Further QIR findings on the growth in corporate quantum mentions.Press & CoverageDiffraqtion Pre-Seed Announcement (PR Newswire) — Official release covering the $4.2M raise, DARPA contract, and founding team.Breaking Defense — DARPA Backs Diffraqtion — The most in-depth interview on the DARPA SBIR contract and programmable light plates.The Quantum Insider — Diffraqtion $4.2M Raise — Investor context including quotes from Chad Rigetti; technical claims on resolution and processing.Payload Space — Diffraqtion Emerges from Stealth — Commercial framing around the 6U CubeSat cost model.Defense One — Quantum Cameras Could Remake Space-Based Intelligence — Policy and defense framing.SponsorCisco Universal Quantum Switch — Outshift by Cisco — Cisco's incubation engine, building a scalable quantum network on open standards and vendor-agnostic architecture.Key Quotes & InsightsOn quantum information loss: "When you do a direct image… you lose something like 95% of information from that photon. So you leave 95% on the table, and the question was: how do you extract that back?"On what "quantum" really means here: Galatsanos is refreshingly candid — the device uses quantum Fisher information theory to set the physical limit and configure the hardware, but the runtime processing is closer to analog photonic computing than to gate-based quantum computing. He describes it as sitting between "quantum 1.0" and quantum sensing.On the frog's-eye analogy: Retinal ganglion cells can process shapes and trajectories faster than the brain — which is why you can catch a baseball or a falling fork before you consciously see it. Diffraqtion is trying to give satellites and robots the same kind of reflex.On the JPEG as a historical artifact: "JPEG was a little bit of a logical step… but now the thought is, forget about it — you don't even need that. The light itself already will tell you." The machine, unlike a human operator, doesn't need an image.On why quantum sensing lags in the discourse: Insight — quantum computing benefits from a single unifying narrative that every vendor can pull on. Quantum sensing has to invent its own story from scratch for each modality, which is a structural PR disadvantage more than a technical one.Related EpisodesEp. 65 — Quantum sensitivity breakthrough with Eli Levenson-Falk — On protocols that push measurements beyond conventional limits; a natural companion to the Fisher information discussion.Ep. 16 — Operating at the Quantum Limit with Dr. Dana Anderson — Infleqtion's CSO on quantum sensing alongside computing; useful context for why sensing is closer to deployment.Ep. 68 — Incubating quantum innovation with Vijoy Pandey of Outshift by Cisco — On quantum networks solving real problems today; a parallel to Diffraqtion's near-term deployment argument.Ep. 63 — A Programming Language for Quantum Simulations with Xiaodi Wu — Also from the University of...

Salvatore Brugaletta joins host Catherine Glass to explore how intracoronary imaging has transformed modern percutaneous coronary intervention (PCI). From intravascular ultrasound and optical CT to stent optimisation, vascular dysfunction, and AI-enhanced image interpretation, this episode examines the technologies improving procedural precision and patient outcomes.  Timestamps:  0:55 – IVUS and OCT  2:58 – Endothelial recovery  4:55 – Stent failure mechanisms  6:19 – Barriers to adoption  8:18 – Innovations in imaging 

Most geospatial data is gathered by satellites and cameras attached to planes, but a new decentralized network is helping amateur drone pilots capture and contribute ultra high resolution data. In this week's show, we go fly a drone and learn how that data is helping power next generation apps for things like disaster response.This episode originally ran in June 2025.We Meet:  Alec Wilson, COO SpexiBill Lakeland, CEO Spexi Credits:This episode of SHIFT was produced by Jennifer Strong with help from Emma Cillekens. It was mixed by Garret Lang, with original music from him and Jacob Gorski. Art by Meg Marco.

Which imaging biomarkers matter most at diagnosis of GA, and how should they shape the decision to treat? In episode 1 of the GA in Practice miniseries on New Retina Radio, moderator Geeta Lalwani, MD, and panelists Murtaza Adam, MD, and Carl Danzig, MD, review the practical role of fundus autofluorescence and OCT in identifying high-risk GA, discuss ellipsoid zone integrity as an emerging endpoint, and work through a hypothetical case of an active, motivated patient with bilateral extrafoveal GA and good vision to explore how lifestyle, lesion characteristics, and patient education factor into early treatment decisions.

Dr. Sepideh Abdi reviews the key imaging features of premalignant bone and soft-tissue conditions, highlighting how radiologists can recognize early signs of malignant transformation in benign tumors and chronically injured tissues. From osteochondromas and enchondromas to neurofibromas, atypical lipomatous tumors, and radiation-induced sarcomas, this episode provides practical takeaways for identifying imaging findings that warrant  closer evaluation and intervention. Imaging of Premalignant Conditions ofBone and Soft Tissue. Abdi et al. RadioGraphics 2025; 45(8):e240172.   

Luke Andrea, MD, and Patrick J. Coppler, PA-C, join CHEST® Journal Podcast Moderator Matt Siuba, DO, MS, to discuss their research into the use of CT and point-of-care ultrasound imaging to identify acute pathologic features that change postarrest management after in-hospital cardiac arrest. DOI: 10.1016/j.chest.2026.02.023 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers' opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.  

Equipping Hour | Imaging God in a Broken World | AI and Transhumanism by OrlandoGrace

Stugotz, Izzy, Taylor and Mikey A play three games including: "Who won the trade?", "Think about it Thursday", and "Taylor fixes American sports with something from soccer". Plus, Izzy redrafts the 2018 NBA draft.See omnystudio.com/listener for privacy information.

Join our online community: https://www.skool.com/nailed-it-ortho/about  Dr. Gianakos Instagram: https://www.instagram.com/dr.ariannagianakos/?hl=en   In this episode, Dr. Ariana Gianakos joins us to talk about sports foot and ankle injuries. We cover common athletic injuries, evaluation strategies, treatment options, rehab, and the challenges of getting athletes safely back to play. Dr. Gianakos shares her journey into sports foot and ankle surgery, how her own athletic injuries shaped her career, and the international fellowship experiences that helped define her approach to treating elite athletes. We also discuss: Common sports-related foot and ankle injuries Key anatomy and physical exam pearls Imaging strategies and when to order MRIs Conservative vs surgical treatment options Return-to-play timelines for athletes Managing instability, tendon injuries, and high ankle sprains The role of PRP, biologics, and peptides in sports medicine Building global consensus in foot and ankle sports care Enjoy! Arianna Gianakos, DO, is an orthopaedic surgeon who specializes in sports-related injuries of the foot and ankle, including Achilles tendon injuries; ankle sprains and instability; ligament reconstruction; and trauma-related foot and ankle fractures, as well as various other foot and ankle conditions. Dr. Gianakos' interest in sports medicine—particularly foot and ankle sports medicine—is the result of a long, personal history with sports. She was an All-American Athlete, former collegiate basketball player, and track and field athlete who had her own share of injuries and orthopaedic surgeries. "My experience taught me the importance of having a physician who was passionate about getting patients back on their feet so they are able to return to sports," she says. "I chose a career where I could help patients in the same way my orthopaedic surgeons helped me." Her approaches include cutting-edge, minimally invasive surgeries, including in-office needle arthroscopy, and a variety of nonsurgical interventions, such as platelet-rich plasma (PRP) therapy, stem cell therapy, and fat cell therapy. In addition to her clinical work, Dr. Gianakos is an assistant professor of Orthopaedics & Rehabilitation at Yale School of Medicine. She has collaborated on studies of cartilage regeneration, tendon healing, and bone growth, and has a personal research focus on gender- and sex-related differences in foot and ankle injuries and outcomes. Dr. Ariana Gianakos earned her Bachelor of Science degree from McGill University before completing her Doctor of Osteopathic Medicine degree at Lake Erie College of Osteopathic Medicine. She went on to complete her orthopedic surgery residency at Rutgers Health, followed by a fellowship in Orthopedic Foot and Ankle Surgery at Massachusetts General Hospital through Harvard Medical School. She also completed advanced international training in foot and ankle IONA and sports medicine through NYU Langone Health. In addition, she is a PhD candidate at the University of Amsterdam, where her research focuses on gender and sex-related differences in foot and ankle surgery.   

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode, Peter explores the critical topic of breast cancer screening, examining why thousands of women continue to die from breast cancer each year despite the availability of effective screening tools. He explains the strengths and limitations of current screening strategies, reviews the recommendations from major medical organizations, and discusses why screening guidance can often seem confusing or contradictory. Peter outlines a practical framework for understanding breast cancer risk and personalizing screening decisions, including when to begin screening, how frequently to screen, and which imaging modalities may be most appropriate based on an individual's risk profile. Throughout the episode, he emphasizes that while population-based guidelines provide an important foundation, optimizing outcomes requires a more personalized approach aimed at helping women make informed screening decisions that can improve the chances of early detection and successful treatment. We discuss: Why women still die from breast cancer: the benefits of screening, the problem of under-screening, and the need for risk-based screening strategies [1:45]; Current screening recommendations, why they differ between organizations, and the importance of personalized screening decisions [6:30]; A framework for personalizing screening [8:45]; Assessing baseline breast cancer risk: genetics, family history, breast density, lifestyle factors, and the role of risk calculators in personalized screening [9:30]; Balancing cancer detection and false positives: how breast cancer risk influences screening intensity and imaging choices [17:45]; Mammography as the foundation of breast cancer screening: detecting ductal carcinoma in situ (DCIS) and the advantages of 3D versus 2D mammography [21:00]; MRI for high-risk women: the benefits of supplemental screening, abbreviated MRI, and the emerging role of contrast-enhanced mammography [23:00]; The role of ultrasound: supplemental cancer detection, diagnostic evaluation, and limitations compared with mammography and MRI [26:00]; Choosing the right breast cancer screening strategy: imaging modality selection, screening hierarchies, and the importance of imaging center quality [28:00]; How often should you screen for breast cancer? [30:15]; At what age should you start screening? [37:30]; Breast cancer in younger women: aggressive tumor biology, BRCA-related risk, breast density, and individualized decisions about when to begin screening [41:45]; Inflammatory breast cancer, the limitations of screening mammography for symptomatic disease, and the importance of promptly evaluating new breast symptoms in both women and men [44:45]; From risk assessment to personalized screening: a practical framework for reducing breast cancer mortality through earlier and more effective detection [46:30]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

A 25-year-old pregnant woman presents with a 1-day history of progressive pain and swelling. The foot is cold, pulseless and neurologic function is deteriorating by the hour. Imaging shows a massive iliofemoral DVT. Now both the limb and the pregnancy are threatened. Do you anticoagulate, thrombolyse or operate? Join us as we break down the management and decision making behind this rare but devastating case.Hosts:·      Christian Hadeed -PGY 4 General Surgery, Brookdale Hospital Medical Center·      Paul Haser -Division Chief, Vascular Surgery, Brookdale Hospital Medical Center·      Andrew Harrington, Vascular surgery, Brookdale Hospital Medical Center·      Lucio Flores, Vascular surgery, Brookdale Hospital Medical CenterLearning objectives:-       Recognize the clinical presentation and pathophysiology of phlegmasia cerulea dolens-       Describe how pregnancy affects decision making in patients with phlegmasia and venous thromboembolic disease-       Discuss the goals of treatment for patients with DVT's and identify when operative intervention is indicated-       Describe the sequelae of DVT's and how this relates to post thrombotic syndrome-       Review the indications, risks, and limitations of anticoagulation, catheter-directed thrombolysis, thrombectomy, and fasciotomy in the management of DVT and phlegmasia.-       Explain the role of IVUS in managing venous thromboembolic disease and May Thurner syndromeReferences:-       Vedantham, S., Goldhaber, S. Z., Julian, J. A., Kahn, S. R., Jaff, M. R., Cohen, D. J., Magnuson, E., Razavi, M. K., Comerota, A. J., Gornik, H. L., Murphy, T. P., Lewis, L., Duncan, J. R., Nieters, P., Derfler, M. C., Filion, M., Gu, C.-S., Kee, S., Schneider, J., … Kearon, C. (2017). Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. New England Journal of Medicine, 377(23), 2240–2252. https://doi.org/10.1056/NEJMoa1615066-       Gomes, M. S., Guimarães, M., & Montenegro, N. (2019). Thrombolysis in pregnancy: A literature review. Journal of Maternal-Fetal & Neonatal Medicine, 32(14), 2418–2428. https://doi.org/10.1080/14767058.2018.1438402-       Mangla, A., & Hamad, H. (2023). May-Thurner syndrome. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554377/-       Bates, S. M., Rajasekhar, A., Middeldorp, S., McLintock, C., Rodger, M. A., James, A. H., et al. (2018). American Society of Hematology 2018 guidelines for management of venous thromboembolism: Venous thromboembolism in the context of pregnancy. Blood Advances, 2(22), 3317–3359. https://doi.org/10.1182/bloodadvances.2018024802-       Kahn, S. R., Comerota, A. J., Cushman, M., Evans, N. S., Ginsberg, J. S., Goldenberg, N. A., et al. (2014). The postthrombotic syndrome: Evidence-based prevention, diagnosis, and treatment strategies. Circulation, 130(18), 1636–1661. https://doi.org/10.1161/CIR.0000000000000130 https://pubmed.ncbi.nlm.nih.gov/25246013/Sponsor URL: https://www.goremedical.com/If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Preview for Later Today: Doug Messier describes NASA's innovative mission using robotic hoppers to survey the lunar South Pole, seeking water and potential sites for a future moon base through high-resolution imaging in the moon's environment.MAY 1952